Award
NIH Reporter #5R01HL173767-03
Heavy Menstrual Bleeding Progestin Treatment in Bleeding Disorders Study
Recipient
National Heart Lung and Blood Institute (NHLBI), part of the NIH, US
Award Amount
$538,341.00
Ceiling
$538,341.00
Awarded
August 17, 2026
Identifier
5R01HL173767-03
NIH grant awarded for a study on progestin treatment for heavy menstrual bleeding in individuals with bleeding disorders, involving clinical trials and outcome assessments.
Description
This is a NIH grant project focusing on menstrual bleeding treatment in adolescents and young adults with bleeding disorders. The project involves clinical trials comparing different hormonal treatments and assessing outcomes related to bleeding management, quality of life, and diagnostic testing impacts.